| Literature DB >> 29755507 |
Fahad A Al-Abbasi1, Kaleemuddin Mohammed1,2, Saida Sadath1, Babajan Banaganapalli2,3, Khalidah Nasser4, Noor A Shaik2,3.
Abstract
The deleterious amino acid substitution mutations in IL-10 receptor alpha gene are most frequently reported in several autoimmune diseases including early onset-inflammatory bowel disease (IBD). Despite the important role of IL-10 RA in maintaining immune homeostasis, the specific structural and functional implications of these mutations on protein phenotype, stability, ligand binding and post translational characteristics is not well explored. Therefore, this study performed the multidimensional computational analysis of IL10RA missense variations causative to pediatric or early onset inflammatory bowel disease (<5 years of age). Our computational algorithmic screening identified the deleterious nature of p. W45G, p. Y57C, p. W69G, p.T84I, p.Y91C, p.R101W, p.R117C, and p.R117H, IBD causative IL10-RA mutations. The sensitivity and specificity analysis of different computational methods showed that CADD outperform SIFT, PolyPhen 2.0, FATHMM, LRT, MetaLR, MetaSVM, PROVEAN and Condel in predicting the pathogenicity of IL10RA mutations. Our three-dimensional protein modeling assays showed that the point mutations cause major drifts in the structural plasticity of IL10 RA molecule and negatively influence its stability. Findings from molecular docking analysis have shown that these point mutations decrease the binding affinity of IL10RA toward IL10 and may likely to disturb the IL10 signaling pathway. This study provides an easy frame work for phenotypic characterization of mutant IL10RA molecule in terms of structure, flexibility and stability aspects. Our approach may also add a new dimension to conventional functional biology assays in quickly studying IL10 RA mutations and also for designing and developing inhibitors for mutant IL10RA molecule.Entities:
Keywords: IL10RA gene; In-silico analysis; inflammatory bowel disease (IBD); molecular docking; pathogenic mutations
Year: 2018 PMID: 29755507 PMCID: PMC5934427 DOI: 10.3389/fgene.2018.00146
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
List of IBD causal IL10RA genetic mutations and their pathogenicity prediction scores.
| c.133T>G | 2/7 | W45G | – | 0 | 1 | 4.8 | −4.77 | 1 | 0.62 | 1.10 | 3.33 | −11.38 | Beser et al., |
| c.170A>g | 2/7 | Y57C | rs201643277 | 0 | 0.998 | 4.7 | −2.69 | 1 | 0.53 | 0.85 | 3.275 | −7.75 | Kotlarz et al., |
| c.205T>C | 3/7 | W69R | – | 0 | 1 | 4.8 | −1.03 | 0.99 | 0.54 | 0.55 | 3.223 | −5.16 | Shim and Seo, |
| c.251C>T | 3/7 | T84I | rs137853580 | 0 | 0.998 | 4.2 | −1.18 | 0.99 | 0.55 | 0.32 | 3.165 | −4.66 | Glocker et al., |
| c.272A>G | 3/7 | Y91C | – | 0 | 1 | 3.9 | −0.78 | 0.99 | 0.14 | −0.11 | 2.64 | −4.29 | Shim et al., |
| c.301C>T | 3/7 | R101W | rs368287711 | 0 | 1 | 6.3 | −1.1 | 0.99 | 0.62 | 0.23 | 3.075 | −6.47 | Kotlarz et al., |
| c.349C>T | 3/7 | R117C | rs759537444 | 0 | 1 | 7.7 | −0.79 | 1 | 0.22 | 0.12 | 2.51 | −4.93 | Kotlarz et al., |
| c.350G>A | 3/7 | R117H | rs199989396 | 0 | 1 | 7.0 | −0.78 | 1 | 0.22 | 0.06 | 2.51 | −2.89 | Shim et al., |
| c.374T>G | 4/7 | L125R | – | 0 | 0.998 | 6.0 | 0.13 | 0.99 | 0.02 | −0.73 | 2.51 | −4.62 | Engelhardt et al., |
| c.421G>A | 4/7 | G141R | rs137853579 | 0.02 | 1 | 3.7 | 0.66 | 1 | 0.02 | −0.84 | 2.455 | −3.43 | Glocker et al., |
| c.506T>C | 4/7 | I169T | rs369219156 | 0.04 | 0.602 | 4.4 | 0.62 | 1 | 0.20 | −0.83 | 2.36 | −2.84 | Kotlarz et al., |
| c.670A>G | 5/7 | I224V | rs2228055 | 0.49 | 0.002 | −2.1 | 1.04 | 0.99 | 0.08 | −0.98 | 0.69 | −0.17 | Moran et al., |
| c.784C>T | 6/7 | R262C | rs149491038 | 0 | 0.88 | 6.8 | 0.29 | 0.99 | 0.11 | −0.85 | 2.33 | −4.59 | Begue et al., |
| c.1234C>T | 7/7 | R412W | rs143538561 | 0.01 | 0.326 | 4.3 | 1.96 | 0.99 | 0.02 | −1.00 | 0.69 | −2.11 | Kelsen et al., |
| c.1235G>A | 7/7 | R412Q | rs117423374 | 1 | 0 | 0.5 | 1.99 | 0.99 | 0.02 | −1.02 | −1.35 | 1.27 | Kelsen et al., |
Two clinically significant point mutations, c.537G>A (Yanagi et al., .
Specificity, sensitivity analysis report of IL10 RA mutation predictions by different computational methods.
| SIFT | 71.43 | 76.92 | 0.695 | 59.26 | 0.19 | 0.4835 |
| Polyphen | 66.29 | 100 | 0.799 | 70.37 | 0.41 | 0.6429 |
| CADD | 85.71 | 100 | 0.923 | 92.59 | 0.86 | 0.8571 |
| FATHMM | 50 | 100 | 0.599 | 55.56 | 0.27 | 0.5 |
| LRT | 100 | 38.46 | 0.5 | 48.15 | −0.03 | 0.3846 |
| SVM | 42.86 | 100 | 0.621 | 70.37 | 0.52 | 0.4286 |
| META LR | 35.71 | 92.31 | 0.599 | 59.26 | 0.19 | 0.2802 |
| Provean | 64.29 | 92.31 | 0.753 | 74.07 | 0.48 | 0.5659 |
| Condel | 57.14 | 100 | 0.799 | 59.26 | 0.2 | 0.5714 |
Dark color indicates higher score and vice versa.
Figure 1ConSurf Output of selected IL10RA mutants. Wild-type sequence of IL10RA with its conservation scale; highly conserved residues in red rectangle; average conserved residues in black rectangles.
Figure 2I-Tasser generated molecular model of IL10RA.
Figure 3Overview of 12 mutated models with superpose center figure. The IL10RA models represented in cartoon and mutated amino acids are represented non-green colored in sticks.
Structural stability prediction scores, secondary structural features and molecular docking analysis of IL10RA models.
| IL10RA | WildType | – | – | – | – | – | −435.89 | – |
| W45G | −4.308 | −5.73 | −4.017 | Extended beta-strand | 0.52 | −469.27 | −33.38 | |
| T57C | −1.043 | 1.02 | −1.073 | H-bonded turn | 0.25 | −474.84 | −38.95 | |
| W69R | −1.193 | −1.86 | −1.212 | H-bonded turn | 0.24 | −409.84 | −26.05 | |
| T84I | −0.466 | 2.1 | −0.264 | Extended beta-strand | 0.22 | −456.65 | −20.76 | |
| Y91C | −0.284 | 1.45 | −0.099 | Loop or irregular | 0.28 | −477.77 | −41.88 | |
| R101W | −0.997 | 0.55 | −1.233 | Extended beta-strand | 0.01 | −386.86 | 49.03 | |
| R117C | −1.906 | 2.22 | −1.787 | Bend | 0.09 | −437.10 | −1.21 | |
| R117H | −2.16 | 1.03 | −2.256 | Bend | 0.15 | −394.61 | 41.28 | |
| L125R | −0.452 | 0.74 | −0.22 | Bend | 0.25 | −469.27 | −33.38 | |
| G141R | −1.016 | 1.28 | −0.924 | Isolated beta-bridge | 0.48 | −460.71 | −24.82 |
RMSD > 0.5 alters protein ionic interaction; $ΔΔG > 0 destabilizes the protein structure.
Figure 4Stereo surface docking view of IL10RA wildtype (RED color) with IL10 (Blue).
Figure 5Molecular surface docking view of selected mutant models. Mutant IL10RA-Y91C (Yellow in color) with IL10 (Blue in color); and mutant IL10RA-R101W (Green in color) with IL10 (Blue in color); Based on Highest to lowest difference in binding energies compared with wildtype docking complex.
Figure 6GeneMania network analysis of IL10RA. Showing its strong network of interactions with important genes in immune system regulation.
Figure 7NetPhos 2.0 result showing post-translational modification.